- Investing Ideas
- /
- Swedish Fast Growing Stocks With High Insider Ownership
Swedish Fast Growing Stocks With High Insider Ownership
Results
91
0 new
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
91 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
CALTX | SEK 206.60 | 0.2% | 111.4% | SEK 11.2b | SEK 221.25 | PS8.5x | E52.9% | n/a | Pharmaceuticals & Biotech | ||
KEBNI B | SEK 1.49 | -1.1% | 3.6% | SEK 404.0m | SEK 2.20 | PS4.4x | E90.4% | n/a | Tech | ||
YUBICO | SEK 269.00 | 0.4% | 169.3% | SEK 23.2b | SEK 267.50 | PE139.9x | E43.8% | n/a | Software | ||
YIELD | SEK 2.37 | 0% | -67.0% | SEK 135.8m | SEK 9.00 | PB1.6x | E103.4% | n/a | Diversified Financials | ||
CTT | SEK 275.00 | -3.8% | 29.7% | SEK 3.4b | n/a | PE33.8x | E24.8% | 1.9% | Capital Goods | ||
MAGLE | SEK 42.00 | -3.2% | 21.4% | SEK 453.6m | SEK 50.00 | PE58.9x | E72.2% | n/a | Pharmaceuticals & Biotech | ||
BIOA B | SEK 152.50 | -34.8% | -49.1% | SEK 13.5b | SEK 336.40 | PS53.4x | E103.4% | 0% | Pharmaceuticals & Biotech | ||
EDYOU | SEK 1.36 | 41.3% | 3.9% | SEK 50.5m | n/a | PS1.5x | E63.1% | n/a | Media | ||
BIOVIC B | SEK 2.96 | 11.9% | -68.8% | SEK 248.8m | SEK 7.90 | PS34.1x | E73.8% | n/a | Pharmaceuticals & Biotech | ||
INCOAX | SEK 2.36 | 2.6% | -21.6% | SEK 255.3m | SEK 3.65 | PS2.6x | E104.9% | n/a | Tech | ||
CRAD B | SEK 43.45 | -3.9% | 56.3% | SEK 1.5b | SEK 57.00 | PE27.3x | E33.9% | n/a | Healthcare | ||
ORGC | SEK 3.33 | -6.2% | -24.3% | SEK 326.7m | SEK 3.00 | PS2.4x | E109.0% | n/a | Materials | ||
CTM | SEK 7.05 | 5.4% | -71.1% | SEK 533.3m | SEK 29.70 | PB0.3x | E115.4% | 0% | Media | ||
FLEXQ | SEK 11.00 | 8.9% | -59.4% | SEK 147.4m | SEK 25.00 | PS1.2x | E111.9% | n/a | Capital Goods | ||
ORT B | SEK 9.06 | -0.2% | 21.8% | SEK 336.0m | SEK 19.50 | PS5.4x | E91.6% | n/a | Healthcare | ||
SENZA | SEK 7.10 | -1.4% | -32.4% | SEK 209.5m | SEK 16.50 | PS4x | E67.8% | n/a | Pharmaceuticals & Biotech | ||
4C | SEK 20.00 | 8.1% | -23.7% | SEK 702.6m | SEK 22.00 | PS2.4x | E108.0% | n/a | Software | ||
EQT | SEK 340.90 | 1.3% | 43.3% | SEK 403.2b | SEK 366.15 | PE115.4x | E56.7% | 1.0% | Diversified Financials | ||
TRUE B | SEK 33.90 | 1.4% | -15.3% | SEK 11.7b | SEK 54.83 | PE24.5x | E21.5% | 1.2% | Software | ||
MIDS | SEK 1.40 | 8.5% | -40.6% | SEK 293.6m | SEK 2.80 | PS4.6x | E89.9% | n/a | Semiconductors | ||
KLAR | SEK 0.32 | -16.6% | -47.7% | SEK 41.0m | SEK 1.00 | PB1.4x | E61.3% | n/a | Pharmaceuticals & Biotech | ||
FNOX | SEK 66.56 | 2.3% | 5.0% | SEK 40.6b | SEK 73.00 | PE62.5x | E22.6% | 0.3% | Software | ||
NIUTEC | SEK 6.60 | -0.6% | -42.5% | SEK 133.2m | SEK 9.50 | PB1.6x | E94.1% | n/a | Capital Goods | ||
EGTX | SEK 6.02 | 0.3% | 45.8% | SEK 1.8b | SEK 13.30 | PS28x | E98.6% | n/a | Pharmaceuticals & Biotech |